Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | HUP-T3; Hu-P-T3; HuPT3; HupT3; HUPT3 |
| Species | Human |
| Cat.No | ABC-TC497S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Pancreas |
| Storage | Liquid Nitrogen |
| Product Type | Human Pancreas Cancer Cell Lines |
HuP-T3 is a human pancreatic carcinoma cell line derived from the ascites of pancreatic cancer patients suffering from carcinomatous peritonitis. These cells exhibit an epithelial morphology when grown in monolayer cultures and possess a population doubling time of approximately 38.6 hours. HuP-T3 cells produce a limited amount of CEA (carcinoembryonic antigen) and display tumorigenicity when transplanted into nude mice, resulting in the formation of poorly differentiated adenocarcinomas. For subculturing purposes, the cells are split at a ratio of 1:4 to 1:10 using trypsin/EDTA for approximately 10-15 minutes.
Why choose HuP-T3 from AcceGen?
HuP-T3 cells from AcceGen offer exceptional quality and viability, characterized by sterility, mycoplasma negativity verified through PCR-based testing, and the absence of various viruses including EBV, HBV, HCV, HHV-8, HIV-1, HIV-2, HTLV-1/2, and MLV. Their identity is confirmed using STR analysis, and they are cultivated under optimal conditions with stringent quality control measures in place to ensure reliability and consistency.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
The HuP-T3 cell line serves as a valuable model for elucidating the intricate biological and biochemical features of pancreatic cancer. It offers a platform to explore and uncover critical factors and the underlying mechanisms that drive invasion and migration in pancreatic cancer. By studying HuP-T3 cells, researchers can gain insights into the molecular pathways and processes involved in the aggressive nature of this disease, ultimately contributing to a deeper understanding of pancreatic cancer and the development of potential therapeutic strategies to combat its progression.
